Article · 16 Sep 2026
Conference abstract
Formulation, optimization and evaluation of Valsartan nanosuspension
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the present study, nanosuspension of valsartan is formulated, optimized and evaluated in order to enhance solubility, dissolution velocity and expected enhanced bioavailability. Valsartan is poorly water-soluble drug having low bioavailability, i.e. 10-25%. A 32 factorial design was employed to study the effect of independent variables that are amount of polaxomer 188 and stirring time on dependent variables, particle size (nm) and polydispersity index. Batch containing 0.75% polaxomer 188 with 2 hours stirring time showed particle size of 216+2.70 nm, with polydispersity index of 0.190. In-vitro dissolution study was performed for optimized batch, pure valsartan drug and marketed formulation and it revealed that valsartan showed pH dependent dissolution profile with maximum release of 67% in pH 6.8 buffer in 20mins while dissolution of pure drug and marketed formulation reaches only 8% and 27% in 20 mins, respectively. At pH 1.2 buffer, 65% of drug has been dissolved for optimized lyophilized nanosuspension after 120 mins while 15% and 38% has been dissolved for pure drug and marketed formulation, respectively within the same time. The pH change promoted valsartan ionization and diffusion of the ionized molecule in the release medium to faster extent. These results indicate the suitability of 32 factorial design for preparation of valsartan loaded nanosuspension significantly and improved dissolution rate, and possibly enhancing fast on set of therapeutic drug effect.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutica Analytica Acta.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sagar Kasturi”

